ATE321129T1 - Verfahren und produkt für die regulation des reaktionsvermögens von zellen auf äussere signale - Google Patents

Verfahren und produkt für die regulation des reaktionsvermögens von zellen auf äussere signale

Info

Publication number
ATE321129T1
ATE321129T1 AT94915385T AT94915385T ATE321129T1 AT E321129 T1 ATE321129 T1 AT E321129T1 AT 94915385 T AT94915385 T AT 94915385T AT 94915385 T AT94915385 T AT 94915385T AT E321129 T1 ATE321129 T1 AT E321129T1
Authority
AT
Austria
Prior art keywords
mekk
mek
amino acid
acid sequence
protein
Prior art date
Application number
AT94915385T
Other languages
English (en)
Inventor
Gary L Johnson
Original Assignee
Nat Jewish Ct Immun & Respirat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Jewish Ct Immun & Respirat filed Critical Nat Jewish Ct Immun & Respirat
Application granted granted Critical
Publication of ATE321129T1 publication Critical patent/ATE321129T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coating With Molten Metal (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94915385T 1993-04-15 1994-04-15 Verfahren und produkt für die regulation des reaktionsvermögens von zellen auf äussere signale ATE321129T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/049,254 US5405941A (en) 1993-04-15 1993-04-15 MEKK protein, capable of phosphorylating MEK

Publications (1)

Publication Number Publication Date
ATE321129T1 true ATE321129T1 (de) 2006-04-15

Family

ID=21958855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94915385T ATE321129T1 (de) 1993-04-15 1994-04-15 Verfahren und produkt für die regulation des reaktionsvermögens von zellen auf äussere signale

Country Status (12)

Country Link
US (2) US5405941A (de)
EP (2) EP0694044B1 (de)
JP (1) JP4127850B2 (de)
KR (1) KR970702294A (de)
AT (1) ATE321129T1 (de)
CA (1) CA2160548A1 (de)
DE (1) DE69434670T2 (de)
FI (1) FI954894A0 (de)
NO (1) NO954094L (de)
NZ (1) NZ266067A (de)
PL (1) PL311142A1 (de)
WO (1) WO1994024159A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663314A (en) * 1992-11-20 1997-09-02 The Board Of Regents Of The University Of Washington Human signal transduction MAPK kinase
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay
US6074861A (en) * 1993-04-15 2000-06-13 National Jewish Center For Immunology And Respiratory Medicine MEKK proteins
US5981265A (en) * 1993-04-15 1999-11-09 National Jewish Center For Immunology And Respiratory Medicine Methods for regulating MEKK protein activity
US6333170B1 (en) * 1993-04-15 2001-12-25 National Jewish Center For Immunology And Respiratory Medicine Method and product for regulating cell responsiveness to external signals
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
US6037136A (en) * 1994-10-24 2000-03-14 Cold Spring Harbor Laboratory Interactions between RaF proto-oncogenes and CDC25 phosphatases, and uses related thereto
CA2172771A1 (en) * 1995-03-28 1996-09-29 Akiyoshi Tani Method for assaying map kinase
US5736381A (en) * 1995-05-19 1998-04-07 Davis; Roger J. Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US6136596A (en) 1995-05-19 2000-10-24 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5910417A (en) * 1996-05-31 1999-06-08 National Jewish Center For Immunology And Respiratory Medicine Regulation of cytokine production in a hematopoietic cell
WO1998018914A1 (en) * 1996-10-31 1998-05-07 Duke University Soluble tie2 receptor
US6300081B1 (en) 1996-11-15 2001-10-09 Cornell Research Foundation, Inc. Activated ras interaction assay
US20020055130A1 (en) * 1997-02-14 2002-05-09 National Jewish Center For Immunology And Respiratory Medicine Method and product for regulating apoptosis
US20050244846A1 (en) * 1997-02-14 2005-11-03 Johnson Gary L MEKK1 proteins and fragments thereof for use in regulating apoptosis
KR100426648B1 (ko) * 1997-03-26 2004-05-31 주식회사 엘지생명과학 고순도의활성화된미토겐활성단백질키네이즈키네이즈-1의제조방법
JP2002502394A (ja) * 1997-05-28 2002-01-22 メルコラ，ダニエル，エー． ストレス活性化プロテインキナーゼ（ｓａｐｋ）経路の阻害及び癌療法に対する細胞の増感
US6312934B1 (en) 1998-03-16 2001-11-06 National Jewish Center For Immunology And Respiratory Medicine Human MEKK proteins, corresponding nucleic acid molecules, and uses therefor
US6897019B1 (en) * 1998-04-17 2005-05-24 Tufts College Methods for treating and preventing insulin resistance and related disorders
US6811992B1 (en) * 1998-05-14 2004-11-02 Ya Fang Liu Method for identifying MLK inhibitors for the treatment of neurological conditions
US6114517A (en) * 1998-12-10 2000-09-05 Isis Pharmaceuticals Inc. Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
US6168950B1 (en) 1999-07-23 2001-01-02 Isis Pharmaceuticals, Inc. Antisense modulation of MEKK1 expression
US6861239B1 (en) * 1999-09-20 2005-03-01 New York University Genes and polynucleotides associated with ultraviolet radiation-mediated skin damage and uses thereof
EP1085093A3 (de) * 1999-09-20 2002-10-30 New York University Gene und Polynukleotide assoziierte mit UV-induzierten Hautschäden und Verwendungen davon
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US6287860B1 (en) * 2000-01-20 2001-09-11 Isis Pharmaceuticals, Inc. Antisense inhibition of MEKK2 expression
DE10020138A1 (de) * 2000-04-14 2001-10-31 Ulf R Rapp Nukleinsäure codierend für zumindest eine raf Teilsequenz mit einer MEKK1 Bindungsstelle
AU8856201A (en) 2000-09-01 2002-03-13 Andel Inst Van Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
US6498035B1 (en) 2000-09-08 2002-12-24 Isis Pharmaceuticals, Inc. Antisense modulation of MEKK3 expression
AU2001296412A1 (en) * 2000-09-29 2002-04-08 Isis Pharmaceuticals, Inc. Antisense modulation of mekk4 expression
US20030212018A1 (en) * 2001-01-16 2003-11-13 Monia Brett P. Antisense modulation of mekk2 expression
US6806293B1 (en) * 2001-03-12 2004-10-19 Darley Pharmaceuticals Ltd Use of pheromone compounds having MAP kinase modulating activity
WO2002076496A1 (en) * 2001-03-22 2002-10-03 Van Andel Institute Anthrax lethal factor inhibits tumor growth and angiogenesis
WO2002098891A2 (en) * 2001-06-05 2002-12-12 Exelixis, Inc. GADs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
US20050227228A1 (en) 2001-06-05 2005-10-13 Lori Friedman Map3ks as modifiers of the p53 pathway and methods of use
US20040019918A1 (en) * 2002-06-05 2004-01-29 Atherogenics, Inc. Human MEKK2 protein and nucleic acid molecules and uses therefor
EP1514558A1 (de) * 2003-09-15 2005-03-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verwendung von MARKK oder MARKK-Antagonisten zur Behandlung von Pathologien die von einer erhöhten oder reduzierten Phosphorylierung des MARK- oder Tau-Proteins charakterisiert ist
JP4898710B2 (ja) 2005-02-11 2012-03-21 メモリアル スローン−ケタリング キャンサー センター 薬剤耐性ｅｇｆｒ突然変異体を検出するための方法および組成物

Also Published As

Publication number Publication date
FI954894L (fi) 1995-10-13
EP0694044A4 (de) 1998-02-04
DE69434670D1 (de) 2006-05-11
EP0755406B1 (de) 2006-03-08
CA2160548A1 (en) 1994-10-27
NO954094L (no) 1995-12-13
EP0694044B1 (de) 2006-03-22
FI954894A7 (fi) 1995-10-13
PL311142A1 (en) 1996-02-05
AU697340B2 (en) 1998-10-01
WO1994024159A1 (en) 1994-10-27
EP0755406A4 (de) 1999-07-14
EP0694044A1 (de) 1996-01-31
JP4127850B2 (ja) 2008-07-30
NO954094D0 (no) 1995-10-13
AU6666394A (en) 1994-11-08
US5405941A (en) 1995-04-11
EP0755406A1 (de) 1997-01-29
KR970702294A (ko) 1997-05-13
DE69434670T2 (de) 2007-01-18
FI954894A0 (fi) 1995-10-13
JPH08509128A (ja) 1996-10-01
US5854043A (en) 1998-12-29
NZ266067A (en) 1997-09-22

Similar Documents

Publication Publication Date Title
ATE321129T1 (de) Verfahren und produkt für die regulation des reaktionsvermögens von zellen auf äussere signale
Eggenberger Evolving Morphologies of Simulated 3d Organisms Based on
Anderson et al. Calcium-dependent regulator of NAD kinase in higher plants
Murray et al. What controls the cell cycle
Nakai et al. Food proteins: properties and characterization
Schulze et al. Mechanisms of thrombopoiesis
Jung et al. Peptide processing and targeting in the neuronal secretory pathway
ATE371029T1 (de) Regelung von elektrostatischen interaktionen an metallionen-bindungsstellen zur stabilisierung von proteinen
ATE423213T1 (de) Erhöhte expression in pflanzen durch verwendung von nicht-translierter leader-sequenz
ATE143694T1 (de) Verfahren zur herstellung eines biologisch- aktiven peptides durch expression von modifizierten speicherproteingenen in transgenetischen pflanzen
DK15182A (da) Fremgangsmaade til fremstilling af recombinant-dna
Varnum‐Finney et al. Amebae of Dictyostelium discoideum respond to an increasing temporal gradient of the chemoattractant cAMP with a reduced frequency of turning: evidence for a temporal mechanism in ameboid chemotaxis
CA2180103A1 (en) Gene encoding adseverin
Boggess et al. The need for agriculture phenotyping:“Moving from genotype to phenotype”
ATE364703T1 (de) Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
Picciano et al. Isolation of protein synthesis initiation factors from rabbit liver
JPS6420095A (en) Polypeptide having anti-blood coagulating action
DE69836220D1 (de) Den zellzyklus regulierende proteine
Lake Ribosome evolution: the structural bases of protein synthesis in archaebacteria, eubacteria, and eukaryotes
Tripp et al. Identification of phosphoproteins correlated with proliferation and cell cycle arrest in Saccharomyces cerevisiae: positive and negative regulation by cAMP-dependent protein kinase.
BG102355A (bg) Метод за стимулиране на клетъчно медиирани имунниотговори чрез насочване на определена генетична последователност
Nilsen-Hamilton et al. Secreted proteins, intercellular communication, and the mitogenic response
Wallach et al. Altered ribosomal particles in senescent nematodes
Fetrow et al. Protein folding: New twists
Morioka et al. Mutualism based on stress: selective synthesis and phosphorylation of a stress protein by an intracellular symbiont

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties